KCNT1 encodes a sodium-gated potassium channel subunit that plays an important role in regulating excitability in neurons. 1 We recently reported heterozygous KCNT1 mutations in a severe form of autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) 2 in which a significant proportion of individuals have comorbidities of intellectual disability (ID), psychiatric features, and refractory seizures. 2 Heterozygous KCNT1 mutations were also described in patients with malignant migrating focal seizures of infancy (MMFSI). 3 A heterozygous KCNT1 mutation has also been described in a patient with leukoencephalopathy and severe epilepsy 4 and a homozygous mutation was reported in a patient with Ohtahara syndrome. 5 The involvement of KCNT1 in the phenotypically distinct disorders ADNFLE and MMFSI suggests that KCNT1 mutations may be associated with a spectrum of phenotypes encompassing focal epilepsy, psychiatric disorders, and epileptic encephalopathies. To investigate this, we studied patients and families with focal epilepsies, including 22 with psychiatric comorbidities, as well as patients with epileptic encephalopathies, including MMFSI, for mutations in KCNT1. We also sought to further explore the mutational spectrum, that is, the positions and classes of KCNT1 mutations, in epileptic disorders as these may provide insights into the resulting pathogenic mechanisms.
Methods
The study was approved by the ethics committees of Western Sealand, the University of South Australia, and Austin Health, Melbourne, Australia. Genomic DNA from study participants was extracted from peripheral blood leukocytes. One hundred forty-three patients, including 92 with focal epilepsies (22 with psychiatric comorbidities), who were negative for CHRNA2, CHRNA4, and CHRNB2 mutations, and 51 unrelated patients with epileptic encephalopathies including 19 with MMFSI, were tested for mutations in KCNT1 using high-resolution melting-curve (HRM) analysis as described previously. 2 Additional Danish, Dutch, and Italian samples underwent targeted resequencing for selected epilepsy genes including KCNT1 using gene panels as described in Data S1 and Table S1 . Variants were validated and familial segregation was analyzed by Sanger sequencing. Whole exome sequencing (WES) was performed as described in Data S1.
Results
We identified a total of 12 new unrelated patients with missense mutations in KCNT1. The mutations are listed in Table 1 along with the clinical features found in each individual. The positions of these mutations within the KCNT1 protein are shown in Figure 1B .
A heterozygous missense mutation KCNT1 c.2782C>T; p.Arg928Cys was identified in family 1 of Danish origin. The mutation cosegregates with the nocturnal frontal lobe epilepsy (NFLE) phenotype (Fig. 1A) and affected individuals showed a mean age of onset of nocturnal seizures of 9 years (range 1-15 years). Learning impairment, memory deficit, and psychiatric problems, including depression, suicide attempt, anxiety, and attention-deficit/hyperactivity disorder (ADHD) occurred in four of five affected family members, consistent with our earlier report of KCNT1 causing ADNFLE with intellectual disability (ID) and psychiatric features. 2 Interictal EEG data available in two individuals (III.6 and IV.5) showed epileptiform abnormalities in the frontotemporal regions (Fig. S1 ). Individual III.1 (Fig. 1A) had frequent nocturnal seizures and died suddenly and unexpectedly during the night at 23 years of age. His death was classified as sudden unexplained death in epilepsy (SUDEP). Although the KCNT1 mutation segregated in his family, we were unable to test this deceased individual for the KCNT1 mutation. Video-polygraphic study of individual IV-5 with the KCNT1 mutation and ADNFLE showed irregularity in the heart rhythm during wakefulness, increasing significantly during sleep especially during the rapid eye movement (REM) periods. These abnormalities included an ST elevation in the J point plus several supraventricular extra systoles, suggesting Brugada syndrome. Whole exome sequencing of individual IV-5 revealed no mutations in any gene listed in Online Mendelian Inheritance in Man (OMIM) as associated with cardiac arrhythmia.
In the analysis of 92 unrelated families with focal epilepsy, a heterozygous KCNT1 mutation c.1193G>A; p.Arg398Gln co-segregating with affected status was identified in family 2 (Fig. 1A) . The family comprised five affected individuals, one with ADNFLE, one with likely ADNFLE, one with focal epilepsy, and two with MMFSI. Notably, in this family the same KCNT1 mutation, p.Arg398Gln can lead to either ADNFLE or MMFSI.
Patient 10 with sporadic NFLE had the KCNT1 mutation c.2782C>T; p.Arg928Cys. Prior to seizure onset the patient had normal intelligence, with subsequent regression (TIQ 78 at 8 years of age), and did not exhibit any psychiatric features. Patient 8, who had multifocal epilepsy with onset associated with limbic encephalitis due to anti-GAD65 antibodies, had the KCNT1 mutation c.1018G>A; p.Val340-Met.
Eight unrelated patients with MMFSI (patients 3-7, 9, 11, and 12) were found to have KCNT1 mutations. These were c.769C>G; p.His257Asp, c.785G>A; Arg262Gln, c.862G>A; p.Gly288Ser (seen in three patients), c.1283G>A; p.Arg428Gln, c.2800G>A; p.Ala934Thr and c.2849G>A; p.Arg950Gln. None of the mutations were present in publicly available variant datasets (dbSNP, NHLBI, Exome Variant Server) and each was predicted to be possibly damaging by both the PolyPhen-2 and SIFT in silico prediction tools, consistent with being pathogenic. Mutations were shown to have occurred de novo in five of the eight patients, consistent with previous reports of de novo KCNT1 mutations in MMFSI. 3, 6, 7 One patient (patient 11) inherited a mutation (p.Ala934Thr) from an unaffected parent who was shown to be mosaic for the KCNT1 mutation by restriction fragment length assays (HhaI and BstUI digests). Quantitation of bands from the BstUI digest indicated that the mutation was present in approximately 60% of peripheral blood derived cells (data not shown).
Discussion
We have identified a total of 12 new unrelated cases (2 families and 10 sporadic) with mutations in KCNT1. All KCNT1 mutations identified both previously [2] [3] [4] [5] [6] [7] [8] [9] and here are missense mutations, with no nonsense or other truncating mutations reported. This suggests that perturbation of normal KCNT1 protein function, rather than loss of function, underlies the pathogenicity associated with KCNT1 mutations. The mutations initially reported in ADNFLE and MMFSI were clustered around the RCK and NAD + binding domains of the protein. [2] [3] [4] More recently, mutations have been reported within the S5 transmembrane segment of the protein, 6, 7, 9 indicating that alteration of other regions of KCNT1 is also pathogenic. Here we report three novel mutations in patients with multifocal epilepsy and MMFSI in or near the S5 and S6 region of the KCNT1 channel subunit. These findings provide further evidence for the contribution of mutations in this region of KCNT1 to the pathogenesis of MMFSI.
Although ID and psychiatric disorders have previously been reported in ADNFLE, these phenotypic features are infrequent in ADNFLE families with mutations in the other ADNFLE-associated genes CHRNA4, CHRNB2, and CHRNA2.
2 Our finding of ADNFLE, intellectual disability, and psychiatric features associated with mutation of KCNT1 in family 1 provides further evidence that KCNT1 mutations cause a distinct form of ADNFLE that is more severe and includes comorbidities. 2, 10 Patients presenting with these features should be tested for KCNT1.
In addition to the neurologic phenotypes observed in the families in this study, one individual in family 1 had cardiac arrhythmia and another had SUDEP, which is thought to have cardiac involvement. 11, 12 This suggests the involvement of KCNT1 mutations in cardiac disorders. Indeed, a KCNT1 mutation has recently been reported in a patient with epilepsy and Brugada syndrome. 13 The coexistence of epilepsy and Brugada syndrome has been reported previously in a family with a sodium channel mutation (SCN5A).
14 Further clinical examination of patients with KCNT1 mutations to look for cardiac features and functional studies of the KCNT1 protein are required to explore the possible relationship between KCNT1 mutations and cardiac arrhythmias.
ADNFLE families with KCNT1 mutations have previously shown 100% penetrance of the mutation. 2 In contrast, in the current study one individual (family 1, III.3) with a KCNT1 mutation did not have seizures. The nonpenetrance showing the protein structure and the locations of the mutations identified in this and previous studies. [2] [3] [4] [5] [6] [7] [8] [9] 13 The KCNT1 protein consists of a small amino-terminal domain, a transmembrane domain containing six transmembrane segments with the pore-loop between segments 5 and 6 and a large intracellular carboxy-terminal domain containing tandem RCK domains and an NAD + binding domain. Mutations seen in this study are indicated by stars and those seen in other studies are indicated by dots. ADNFLE mutations are marked in red, MMFSI mutations in blue, the leukoencephalopathy mutation in yellow, the mutation seen in the multifocal epilepsy patient in blue-green, and mutations seen in both ADNFLE and MMFSI patients in green. The homozygous mutation seen in Ohtahara syndrome is marked in orange and the mutation seen in Brugada syndrome is marked in dark gray. Mutations observed in multiple families/patients are indicated by the numbers in bold type. Epilepsia ILAE in this individual is unlikely to be due to somatic mosaicism, as she is inferred to have inherited a KCNT1 mutation from her affected mother (II.2, deceased and unavailable for mutation analysis). Thus her unaffected status is most likely due to incomplete penetrance, which has not been previously described for KCNT1 mutations.
In this study, we have identified recurrent mutations in KCNT1, with p.Gly288Ser found three times and p.Arg928Cys seen twice, suggesting that there are mutational "hot spots" in KCNT1. Consistent with this, some mutations identified in the 12 patients described here have been seen previously in other patients, with 5 of the 16 different KCNT1 mutations described to date being observed multiple times (Fig. 1B) . This is likely due to the occurrence of these mutations in CpG di-nucleotides, which are particularly susceptible to mutation. 15 Therefore, it is emerging that there are recurrent pathogenic mutations in KCNT1. This is important when making diagnoses for patients.
Somatic mosaicism of the KCNT1 mutation p.Ala934Thr was observed in the unaffected parent of one patient (patient 11), with the mutation estimated to be present in 60% of peripheral blood cells. This indicates that significant levels of somatic mosaicism of KCNT1 mutations can exist without causing an overt phenotype. Parental mosaicism of a KCNT1 mutation poses the risk of recurrence of affected offspring; thus this finding has important implications for the genetic counseling of families with KCNT1 mutations.
Although seizures are the predominant feature so far associated with KCNT1 mutations, this study highlights the pleiotropic effects of mutations in this gene. The severity of the observed epilepsy phenotypes ranges from mild (a single seizure) to severe (epileptic encephalopathy). Moreover, we report here that the same KCNT1 mutation, p.Arg398Gln can lead to either ADNFLE or MMFSI within the same family, indicating that genotype-phenotype correlations are not straightforward. The association of both phenotypes with the p.Arg398Gln mutation was unexpected, as previous data indicated that mutations associated with MMFSI cause a significantly larger increase in current amplitude than those associated with ADNFLE in mutant KCNT1 channels expressed in vitro in Xenopus oocytes, providing an explanation for how different mutations cause different phenotypes. 8 However, a more recent study 9 shows that the p.Gly288Ser mutation can also cause both phenotypes. Furthermore, that study 9 did not show the same pattern of differences in the current increases as the original study, 8 casting doubt on the conclusion that differences in the increase in current amplitude caused by the different mutations explain the different phenotypes associated with KCNT1 mutations. The association of the different phenotypes with the same mutation may instead be the result of either genetic modifiers or environmental factors.
In summary, our study confirms the role of KCNT1 in severe ADNFLE with intellectual and psychiatric comorbidities and in MMFSI. We show that KCNT1 also plays a role in focal and possibly in multifocal epilepsy and raise the possibility of an additional role in cardiac disorders and SUDEP. As with a number of genes containing mutations of major effect in neurologic disorders, deciphering genotypephenotype correlations for KCNT1 mutations is emerging as challenging. However, the identification of a KCNT1 mutation in individuals presenting with a seizure phenotype will provide patients with a molecular diagnosis for their previously unsolved disorder. As more is learned about the effects of KCNT1 mutations, we anticipate there will be improvements in the therapeutic treatment of patients.
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